TY - JOUR
T1 - Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of dengue virus infection
AU - Namekar, M.
AU - Ellis, E.M.
AU - O'Connell, M.
AU - Elm, J.L.S.B.
AU - Gurary, A.
AU - Park, S.Y.
AU - Imrie, Allison
AU - Nerurkar, V.R.
PY - 2013
Y1 - 2013
N2 - We evaluated the FDA-cleared InBios dengue virus (DENV) IgM capture enzyme-linked immunosorbent assay (ELISA) for qualitative detection of anti-DENV IgM antibodies from 79 serum samples obtained from dengue virus-infected patients or suspected dengue cases. The agreement, sensitivity, and specificity of the InBios assay compared to the gold standard in-house DENV IgM capture ELISA were 94, 92, and 94%, respectively. We conclude that the InBios DENV IgM capture ELISA can be effectively used for rapid diagnosis of acute or recent DENV infection. Copyright © 2013, American Society for Microbiology. All Rights Reserved.
AB - We evaluated the FDA-cleared InBios dengue virus (DENV) IgM capture enzyme-linked immunosorbent assay (ELISA) for qualitative detection of anti-DENV IgM antibodies from 79 serum samples obtained from dengue virus-infected patients or suspected dengue cases. The agreement, sensitivity, and specificity of the InBios assay compared to the gold standard in-house DENV IgM capture ELISA were 94, 92, and 94%, respectively. We conclude that the InBios DENV IgM capture ELISA can be effectively used for rapid diagnosis of acute or recent DENV infection. Copyright © 2013, American Society for Microbiology. All Rights Reserved.
U2 - 10.1128/JCM.00351-13
DO - 10.1128/JCM.00351-13
M3 - Article
C2 - 23824771
SN - 0095-1137
VL - 51
SP - 3102
EP - 3106
JO - Journal of Clinical Microbiology
JF - Journal of Clinical Microbiology
IS - 9
ER -